June 1, 2022
ViiV Healthcare’s Vocabria (cabotegravir) injection and tablets and Janssen Pharmaceutical’s Rekambys (rilpivirine long-acting injectable suspension) will be added to the NHI price list on June 8 for HIV treatment. A key health ministry panel approved their fast-tracked listing on June...read more